The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date by Antza C, Nirantharakumar K, Doundoulakis I, Tahrani AA, Toulis KA

Get full text

Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women by Caleyachetty, R, Thomas, GN, Toulis, KA, Mohammed, N, Gokhale, KM, Balachandran, K, Nirantharakumar, K

Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies by Ho, IS-S, Azcoaga-Lorenzo, A, Akbari, A, Black, C, Davies, J, Hodgins, P, Khunti, K, Kadam, U, Lyons, RA, McCowan, C, Mercer, S, Nirantharakumar, K, Guthrie, B

Systematic approach to outcome assessment from coded electronic healthcare records in the DaRe2THINK NHS-embedded randomized trial by Wang, X, Mobley, AR, Tica, O, Okoth, K, Ghosh, RE, Myles, P, Williams, T, Haynes, S, Nirantharakumar, K, Shukla, D, Kotecha, D, Allen, N, Baigent, C, McManus, R

Individualized prevention of proton pump inhibitor related adverse events by risk stratification by Xia, B, He, Q, Smith, FG, Gkoutos, VG, Nirantharakumar, K, Kuo, ZC, Wang, D, Feng, Q, Cheung, EC, Dai, L, Huang, J, Yu, Y, Meng, W, Qin, X, Yuan, J

The optimal second-line therapy for older adults with type 2 diabetes mellitus: protocol for a systematic review and network meta-analysis using individual participant data (IPD) by Wang, J, Nirantharakumar, K, Sainsbury, C, Moore, DJ, Sinclair, A, Thomas, GN, Hanif, W, Singh, M, Tan, L, Wang, Z, Simms-Williams, N, Yao, M, Gunathilaka, MN, Singh, P, Toulis, K, Tsapas, A, Coomar, D, Price, MJ